BridgeBio Pharma, Inc., 10% Owner at Eidos Therapeutics, Inc. (EIDX), bought 2,207,696 shares at $25.93 ($57.2M) on 2019-05-24, disclosed to the SEC on 2019-05-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.93 | 1,103,848 | $28.6M | 50.0% |
| 2 | $25.93 | 1,103,848 | $28.6M | 50.0% |
| Total | $25.93 avg | 2,207,696 | $57.2M | 100% |